计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab175467-100μg |
100μg |
现货 ![]() |
| |
| Ab175467-1mg |
1mg |
现货 ![]() |
| |
| Ab175467-5mg |
5mg |
现货 ![]() |
| |
| Ab175467-10mg |
10mg |
期货 ![]() |
|
| 产品名称 | Belantamab mafodotin (anti-BCMA), B 细胞成熟抗原抗体 |
|---|---|
| 别名 | BCMA抗体 | BCMA单克隆抗体 | BCMA药靶抗体 | TNFRSF17抗体 | TNFRSF17单克隆抗体 | TNFRSF17药靶抗体 | CD269抗体 | CD269单克隆抗体 | CD269药靶抗体 |
| 英文别名 | B cell maturation antigen antibody | B cell maturation factor antibody | B cell maturation protein antibody | B-cell maturation protein antibody | BCM antibody | BCMA antibody | CD269 antibody | CD269 antigen antibody | TNFRSF17 antibody | TNR17_HUMAN ant |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥90%(SDS-PAGE&SEC-HPLC), 见COA |
| 生化机理 | Receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. Promotes B-cell survival and plays a role in the regulation of humoral immunity. Activates NF-kappa-B and JNK. |
| 宿主种属 | 人(Human) |
| 特异性 | TNFRSF17 |
| 种属反应性 | 人(Human),食蟹猴(Cynomolgus monkey) |
| 偶联 | MC-VC-PAB-MMAF |
| 作用类型 | 结合剂 |
| 作用机制 | B 细胞成熟抗原抗体 |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG1 |
| 轻链亚型 | kappa |
| SDS-PAGE | 145 kDa |
| 纯化方法 | Protein A purified |
| 纯度 | >90% (SDS-PAGE&SEC) |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle. |
| CAS编号和信息 | 2050232-20-5 |
| 分子类型 | 抗体偶联药物 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
Belantamab mafodotin (anti-BCMA) (Ab175467) - Flow Cytometry
Flow Cytometry analysis of U266 cells labelling BCMA (red) with Belantamab mafodotin (anti-BCMA) (Ab175467) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Belantamab mafodotin (anti-BCMA) (Ab175467) - ELISA
Immobilized Recombinant Human BCMA/TNFRSF17(Fc) protein (rp169554) at 1.0 μg/mL can bind Belantamab mafodotin (anti-BCMA) (Ab175467) with the EC50 of 40.09 ng/mL.
Belantamab mafodotin (anti-BCMA) (Ab175467) - ELISA
Immobilized Recombinant huBCMA- ECD-His protein at 2.0 μg/mL can bind Belantamab mafodotin (anti-BCMA) (Ab175467) with the EC50 of 26.34 ng/mL.
Belantamab mafodotin (anti-BCMA) (Ab175467) - SEC
The purity of Belantamab mafodotin (anti-BCMA) (Ab175467) is more than 95% verified by HPLC.
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Ab175467 | |
| 分析证书 | Ab175467 | |
| 分析证书 | Ab175467 |
| 1. Nooka AK, Weisel K, van de Donk NW, Routledge D, Otero PR, Song K, Quach H, Callander N, Minnema MC, Trudel S et al.. (2021) Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design.. Future Oncol, 17 (16): (1987-2003). [PMID:33682447] |
| 2. Popat R, Warcel D, O'Nions J, Cowley A, Smith S, Tucker WR, Yong K, Esposti SD. (2020) Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial.. Haematologica, 105 (5): (e261-e263). [PMID:32107339] |